Home Platform
Differentiation
About Team News Investors

Run a Compound

Tell us about your compound.

Whether a candidate has failed safety review or you want to know where it stands before it does, start here. A member of our team will follow up to begin the conversation.

How It Works

From inquiry to answer.

  • 1

    Send a quick inquiry

    A few details about you and the compound. No structures or confidential data needed at this stage.

  • 2

    We reach out

    Our team contacts you directly to understand the program and put any confidentiality terms in place.

  • 3

    Run it through HARMONY

    HARMONY identifies why the compound fails on safety, then generates the fix.

Please don't include confidential structures or data. We'll arrange that once we're in touch.

Thank you.

Your inquiry is in. A member of the InfiniGraph team will reach out to you shortly.

What's Riding on Every Compound

Every compound has years of work behind it.

10–15 years

From idea to approval

Don't start over

If a drug fails on safety, recovery builds on the years of work behind it instead of going back to square one.

~$2.6B

Average cost per approved drug, counting failures

Protect the investment

Finding a safety problem early, or fixing one that already happened, keeps that spend from being written off.

1 in 10

Drugs entering human trials that get approved

Improve the odds

Screen pipeline compounds for safety risks before they reach the clinic.

Let's make sure yours gets a second chance.

Industry estimates. Sources: DiMasi et al., Journal of Health Economics (2016); Sun et al., Acta Pharmaceutica Sinica B (2022).